A commonly prescribed dementia drug could hold the key to helping prevent debilitating falls for people with Parkinson’s, scientists have discovered. Parkinson’s affects approximately seven million worldwide. 70% of people with Parkinson’s will fall at least once a year, with over a third experiencing falls repeatedly, resulting in fractures, broken bones and hospital admissions.